Global Artificial Heart Valve Market - Technologies, Market Share and Industry Forecast to 2024: Huge Growth Opportunity in Emerging Economies - ResearchAndMarkets.com

October 12, 2018

DUBLIN--(BUSINESS WIRE)--Oct 12, 2018--The “Global Artificial Heart Valve Market- Technologies, Market share and Industry Forecast to 2024” report has been added to ResearchAndMarkets.com’s offering.

Global artificial heart valve market is expected to rise with the CAGR of about 12% during the forecast period.

Emergence of MRI-conditional heart valves is the one of the key trend of the market. Key drivers fueling growth in the global market for artificial heart valve market are increasing geriatric population and rise in prevalence of heart valve diseases. With rise in the number of heart patients, artificial heart valve device demand is expected to propel its implantation in the heart patient.

The rise in the number of heart disease patient base is expected to highly boost the adoption of artificial heart valve for the implantation in the heart patients.

Rising number of vascular disorders is expected to boost the demand of artificial heart valve market in the forecast period and expected to offer lucrative growth to the global artificial heart valve market globally.

In addition, increasing government funding for heart valve research, rising awareness about heart valve diseases, regulatory approvals for new and advanced prosthetic heart valves, and favorable reimbursement scenario are also adding growth in the market.

However, high cost and risk associated with Transcatheter Aortic Valve Replacement (TAVR) procedures and strict approval process are hindering the market growth.

Rising demand for minimally invasive surgery is the growth promoter of the market. This increasing adoption of minimally-invasive cardiac surgery is adding growth in the global artificial heart valve market.

Transcatheter heart valves are widely adopted in the minimally invasive heart surgeries. Increasing preference for the minimally invasive surgeries is highly boosting the market. Transcatheter heart valve segment is expected to boost the market as they are widely adopted in the minimally-invasive heart surgeries.

Market Dynamics


Rising Geriatric Population and Life Expectancy Rate Favourable Compensation and Regulatory Approvals Growing Government Investment for Heart Valve Research and Analysis Growing Prevalence of Heart Diseases


High Cost and Risk Associated With Replacement Procedures Stringent Regulatory Approval Process


Strong Product Pipeline Huge Growth Opportunity in Emerging Economies


Availability of Alternative Methods

Key Topics Covered

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Competitive Landscape

6. Geographic Analysis

7. Company Profiles

Boston Scientific Corporation (U.S.) Braile Biomedica (Brazil) Colibri Heart Valve LLC (U.S.) Cryolife Inc. (U.S.) Edwards Lifesciences Corporation (U.S.) Heart Leaflet Technology (U.S.) Jenavalve Technology Inc.(Germany) Leman Cardiovascular (Switzerland) Lepu Medical Technology Co Ltd (China) Livanova PLC (U.K.) Medtronic PLC (Ireland) Micro Interventional Devices Inc. (U.S.) St. Jude Medical Inc. (an Abbott Laboratories Company) (U.S.) Symetis S.A. (Switzerland) TTK Healthcare Limited (A TTK Group Company) (India)

For more information about this report visit https://www.researchandmarkets.com/research/st2m2h/global_artificial?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181012005318/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Devices



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/12/2018 11:18 AM/DISC: 10/12/2018 11:18 AM


Update hourly